Current:Home > StocksWill artificial intelligence help — or hurt — medicine? -DataFinance
Will artificial intelligence help — or hurt — medicine?
View
Date:2025-04-12 04:31:55
A doctor's job is to help patients. With that, very often comes lots and lots of paperwork. That's where some startups are betting artificial intelligence may come in.
NPR science correspondent Geoff Brumfiel has been looking into the use of AI in the medical field and he brings us an age old question: Do the benefits outweigh the risks?
Dereck Paul hopes the answer is yes. He's a co-founder of the startup Glass Health. Dereck was an early skeptic of chatbots. "I looked at it and I thought it was going to write some bad blog posts ... who cares?" But now, he's excited about their experimental feature Glass AI 2.0. With it, doctors can enter a short patient summary and the AI sends back an initial clinical plan, including potential tests and treatments, Dereck says. The goal is to give doctors back time they would otherwise use for routine tasks.
But some experts worry the bias that already exists in the medical system will be translated into AI programs. AI "has the sheen of objectivity. 'ChatGPT said that you shouldn't have this medication — it's not me,'" says Marzyeh Ghassemi, a computer scientist studying AI and health care at MIT. And early independent research shows that as of now, it might just be a sheen.
So the age old answer to whether the benefits outweigh the risks seems to be ... time will tell.
Listen to Short Wave on Spotify, Apple Podcasts and Google Podcasts.
Have a lead on AI in innovative spaces? Email us at shortwave@npr.org!
This episode was produced by Berly McCoy, edited by Rebecca Ramirez and fact checked by Nicolette Khan. The audio engineer was Robert Rodriguez.
veryGood! (8323)
Related
- House passes bill to add 66 new federal judgeships, but prospects murky after Biden veto threat
- Woman sentenced to 25 years after pleading guilty in case of boy found dead in suitcase in Indiana
- Comparing Netflix's 'Squid Game The Challenge' reality show to the OG: Dye, but no dying
- German police raid homes of 17 people accused of posting antisemitic hate speech on social media
- South Korean president's party divided over defiant martial law speech
- Abortion access protection, assault weapons ban to be heard in Virginia’s 2024 legislative session
- Deaths from gold mine collapse in Suriname rise to 14, with 7 people still missing
- Blue Bloods Is Officially Ending After 14 Seasons
- 'No Good Deed': Who's the killer in the Netflix comedy? And will there be a Season 2?
- New Jersey banning sale of new gasoline-powered vehicles by 2035
Ranking
- Mets have visions of grandeur, and a dynasty, with Juan Soto as major catalyst
- In wake of Voting Rights Act ruling, North Dakota to appeal decision that protected tribes’ rights
- As 2023 draws to close, Biden’s promised visit to Africa shows no signs of happening yet
- UN warns food aid for 1.4 million refugees in Chad could end over limited funding
- McConnell absent from Senate on Thursday as he recovers from fall in Capitol
- Stockholm city hall backs Olympic bid ahead of key IOC meeting for 2030-2034 Winter Games candidates
- Judge overseeing Idaho murders case bars media cameras, citing intense focus on suspect — but the court will livestream
- Negotiators near deal with Hamas to release hostages
Recommendation
Charges tied to China weigh on GM in Q4, but profit and revenue top expectations
The Rolling Stones are going back on tour: How to get tickets to the 16 stadium dates
'Repulsive and disgusting': Wisconsin officials condemn neo-Nazi group after march in Madison
UK took action too late against COVID-19 during first wave of pandemic, top medical officer says
Questlove charts 50 years of SNL musical hits (and misses)
What's a DINK? Childless couples in US could soon hit 50% and these states rank high for them
New Jersey banning sale of new gasoline-powered vehicles by 2035
Tom Brady decries NFL's quality of play: 'A lot of mediocrity'